Fernandes J R, Seymour R J, Suissa S
Department of Obstetrics and Gynaecology, McGill University, Montreal, Quebec, Canada.
Am J Obstet Gynecol. 1988 Feb;158(2):244-9. doi: 10.1016/0002-9378(88)90131-7.
Patients with concomitant ovarian cancer and bowel obstruction were studied in an effort to find objective prognostic factors predictive of patient outcome. A total of 62 patients were followed from 31 to 354 weeks, and a total of 20 variables were considered in the analyses. At the end of the study 49 patients were dead of their disease, and 13 were alive (six disease free and seven with persistent disease). Survival probabilities of the sample were 79% at 6 weeks, 48% at 20 weeks, and 24% at 104 weeks. Univariate analyses revealed no significant difference in the survival times of medically versus surgically treated patients; age greater than 60 years at diagnosis of cancer, presence of ascites, low serum albumin levels, elevated blood urea nitrogen levels, elevated alkaline phosphatase levels, lack of previous radiotherapy (p less than 0.002 for all), advanced tumor stage, normal/ileus x-ray results, and a short diagnosis to obstruction interval (p less than 0.04 for all) resulted in lower survival probabilities.
对伴有卵巢癌和肠梗阻的患者进行了研究,以寻找预测患者预后的客观预后因素。共对62例患者进行了31至354周的随访,分析中总共考虑了20个变量。研究结束时,49例患者死于疾病,13例存活(6例无病存活,7例疾病持续存在)。样本的生存概率在6周时为79%,20周时为48%,104周时为24%。单因素分析显示,药物治疗与手术治疗患者的生存时间无显著差异;癌症诊断时年龄大于60岁、存在腹水、血清白蛋白水平低、血尿素氮水平升高、碱性磷酸酶水平升高、既往未接受放疗(所有p均小于0.002)、肿瘤分期晚、X线检查结果正常/肠梗阻以及从诊断到梗阻的间隔时间短(所有p均小于0.04)导致生存概率降低。